Table 3 summarizes thediagnostic criteria used by neurologists, including reliance on biomarkers, imaging and cognitive testing. Table 4shows neurologists' preferred medications for managing early-stage AD, highlighting cholinesterase inhibitors as the most common choice.Table 5 presents the types of non-pharmacologic interventions neurologists recommend, includingcognitive therapy and lifestyle changes. Table 6 indicates the frequency with which neurologistscounsel patients and caregivers, underscoring the emphasis on education. Here, BCHE is linked to Alzheimer disease.